Description
Travast 0.004% Ophthalmic Solution is a sterile, preservative-free eye drop manufactured by Incepta Pharmaceuticals Ltd., containing Travoprost 0.004% as the active ingredient. Travoprost is a synthetic prostaglandin F2α analogue that reduces elevated intraocular pressure (IOP) by increasing the drainage of aqueous humor, primarily through increased uveoscleral outflow and to a lesser extent, trabecular outflow. It is indicated for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension who are intolerant of or insufficiently responsive to other intraocular pressure-lowering medications, either as monotherapy or adjunctive therapy. The recommended dosage is one drop in the conjunctival sac of the affected eye(s) once daily in the evening. If more than one topical ophthalmic product is being used, the medicines must be administered at least 5 minutes apart. When substituting another ophthalmic antiglaucoma agent with Travast, discontinue the other agent and start the following day with Travast. Common side effects include ocular hyperemia. Travast should be used with caution in patients with active intraocular inflammation (iritis/uveitis). It is contraindicated in patients with hypersensitivity to Travoprost or any excipients of this preparation. Travast should not be administered while wearing contact lenses; they should be removed prior to the administration of the solution and may be reinserted 15 minutes following administration. Store in a cool, dry place, protected from light, and keep out of reach of children. Discard the container 4 weeks after opening. Travast is available in a 3 ml dropper bottle
.webp)
 100 IU 3 ML.webp)
.jpg)
.jpg)
.jpeg)
.png)
.jpg)
 400MG.jpg)
.jpeg)
.jpg)
.webp)
.jpg)
.webp)
.jpg)
.jpeg)
.jpg)
.jpg)
.jpeg)
Change Language